Mediar Therapeutics
PrivateLast Round
Series B
Jan 7, 2026
Total Funding Raised
$181M
Momentum Score
25 /100
Company Overview
Mediar Therapeutics is a biotechnology company focused on developing innovative treatments for fibrosis aimed at halting and reversing fibrotic activity through the use of antibodies that neutralize mediators involved in chronic organ damage.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mediar Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Mediar Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 7, 2026 | ||||
| Series A | Mar 15, 2023 | ||||
| Seed | Mar 17, 2021 |
Mediar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Seed |
| Gimv | Series A |
| Asahi Kasei Pharma Venture Capital | Series B |
| Amplitude Ventures | Series B |
| Mass General Brigham Innovation | Seed |
| Intermediate Capital Group | Series B |
| Novartis Venture Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
$76M round completed.
Mediar Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mediar Therapeutics's valuation, stock price, and market status.
